Stay updated with breaking news from Evoke Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 40,700 shares, an increase of 6.0% from the April 30th total of 38,400 shares. Approximately 0.6% of the company’s shares are sold short. Based on an […]
StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.1 % EVOK opened at $0.43 on Tuesday. The company has a market cap of $3.71 million, a price-to-earnings ratio […]
StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.1 % NASDAQ EVOK opened at $0.43 on Tuesday. The stock has a market cap of $3.71 million, a […]
StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 2.2 % NASDAQ:EVOK opened at $0.47 on Thursday. Evoke Pharma has a twelve month low of $0.42 and a twelve month […]
A new clinical practice update from AGA covers cannabinoid hyperemesis syndrome that is triggered by chronic cannabis use and manifests with GI symptoms. Underdiagnosis remains a challenge.